Muhammed OYLUMLU, Serdar SOYDİNÇ, Mehmet Zihni BİLİK, Hasan KAYA, Faruk ERTAŞ, Mustafa OYLUMLU

İmplante Edilen Kardiyoverter Defi brilatörlerin Uygunsuz Şokunun Nadir Bir Nedeni: Tremor

İmplante edilen kardiyoverter defi brilatörler primer ve sekonder korumada ani ölümü önlemek amacıyla yaygın olarak kullanılmaktadır. Bu cihazlar gerektiği zaman doğru akım şoku uygulayarak ventriküler taşikardi ve ventriküler fi brilasyon ataklarını sonlandırmaktadır. Ancak bu yararlı etkilerine rağmen uygunsuz şok implante edilen kardiyoverter defi brilatörlerin önemli bir yan etkisi olarak kalmaya devam etmektedir. Uygunsuz implante edilen kardiyoverter defi brilatör şokları hastalarda ağrı ve psikolojik yan etkilere neden olarak yaşam kalitesini bozmakta, hatta yeni aritmi gelişimini indükleyebilmektedir. Bu yazıda tremorun neden olduğu uygunsuz implante edilen kardiyoverter defi brilatör şoku alan bir olgu sunulmaktadır

Unusual Cause of Inappropriate Implantable Cardioverter Defi brillators’ Shock: Tremor

Implantable cardioverter defi brillators are widely used for primary and secondary prevention from sudden death. These devices terminate attacks of ventricular tachycardia and ventricular fi brillation by applying direct current shock, if it necessary. Despite these benefi cal effects, inappropriate shocks are important side effects of implantable cardioverter defi brillators. Inappropriate implantable cardioverter defi brillator shocks impair life quality by causing pain and psychological side-effects, and even induce new arrhytmias. In this paper we present a case of inappropriate implantable cardioverter defi brillator shock due to tremor

PDF

___

1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defi brillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-40.
2. Grimm W, Flores BT, Marchlinski FE. Shock occurrence and survival in 241 patients with implantable cardioverter-defi brillator therapy. Circulation 1993;87:1880-8.
3. Nunain M, Roelke T, Trouton S, Osswald YH, Kim G, Sosa-Suarez, et al. Limitations and late complications of third-generation automatic cardioverter defi brillators. Circulation 1995;91:2204-13.
4. Nanthakumar K, Paquette M, Newman D, Deno DC, Malden L, Gunderson B, et al. Inappropriate therapy from atrial fi brillation and sinus tachycardia in automated implantable cardioverter de- fi brillators. Am Heart J 2000;139:797-803.
5. Johnson NJ, Marclinski FE. Arrythmias induced by device antitachycardia therapy due to diagnostic non-specifi city. J Am Coll Cardiol 1991;18:1418-25.
6. Lüderitz B, Jung W, Deister A, Marneros A, Manz M. Patient acceptance of the implantable cardioverter defi brillator in ventricular tachyarrhythmias. Pacing Clin Electrophysiol 1993;16:1815-21.
7. Rosenqvist M, Beyer T, Block M, den Dulk K, Minten J, Lindemans F. Adverse events with transvenous implantable cardioverter-de- fi brillators: a prospective multicenter study. European 7219 Jewell CD investigators. Circulation 1998;98:663-70.
8. Barakpour H, Emkanjoo Z, Alizadeh A, Sadr-Ameli MA. Inappropriate shock delivered by Implantable Cardioverter Defi brillatorCardiac Resynchronization Therapy (ICD-CRT) due to myopotential oversensing. Indian Pacing Electrophysiol J 2009;9:71-4.
9. Babuty D, Fauchier L, Cosnay P. Inappropriate shocks delivered by implantable cardiac defi brillators during oversensing of activity of diaphagmatic muscle. Heart 1999;81:94-6.